Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of exendin and analogs thereof to delay or prevent cardiac remodeling

Use of exendin and analogs thereof to delay or prevent cardiac remodeling

US Patent 8946149 · Granted Feb 3, 2015

Estimated economic value: $25,373,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for treatment of primary biliary cholangitis2022
Administration of an anti-obesity compound to individuals with renal impairment2017
Administration of an anti-obesity compound to individuals with renal impairment2015
Methods of treating obesity with two different anti-obesity agents2013
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2006
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2005
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2005
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2005
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2005
Production of adenine nucleotide translocator (ANT), novel ANT ligands and scree2005
Indicators of altered mitochondrial function in predictive methods for determini2003
Indicators of altered mitochondrial function in predictive methods for determini2001